4.56
price up icon0.88%   0.04
after-market Handel nachbörslich: 4.52 -0.04 -0.88%
loading
Schlusskurs vom Vortag:
$4.52
Offen:
$4.5
24-Stunden-Volumen:
4.23M
Relative Volume:
0.74
Marktkapitalisierung:
$977.38M
Einnahmen:
$2.59M
Nettoeinkommen (Verlust:
$-137.89M
KGV:
-5.6296
EPS:
-0.81
Netto-Cashflow:
$-69.76M
1W Leistung:
-1.94%
1M Leistung:
+7.04%
6M Leistung:
+193.25%
1J Leistung:
+273.77%
1-Tages-Spanne:
Value
$4.225
$4.60
1-Wochen-Bereich:
Value
$4.225
$4.83
52-Wochen-Spanne:
Value
$1.03
$5.34

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Firmenname
Atai Life Sciences N V
Name
Telefon
49 89 2153 9035
Name
Adresse
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Name
Mitarbeiter
54
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-11
Name
Neueste SEC-Einreichungen
Name
ATAI's Discussions on Twitter

Vergleichen Sie ATAI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATAI
Atai Life Sciences N V
4.56 983.81M 2.59M -137.89M -69.76M -0.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-29 Eingeleitet Oppenheimer Outperform
2024-11-18 Bestätigt H.C. Wainwright Buy
2024-04-03 Hochstufung Maxim Group Hold → Buy
2022-11-01 Eingeleitet Loop Capital Buy
2021-11-30 Eingeleitet Maxim Group Buy
2021-11-11 Eingeleitet ROTH Capital Buy
2021-10-18 Eingeleitet H.C. Wainwright Buy
2021-09-01 Eingeleitet Jefferies Buy
2021-07-13 Eingeleitet Berenberg Buy
2021-07-13 Eingeleitet Canaccord Genuity Buy
2021-07-13 Eingeleitet Cantor Fitzgerald Buy
2021-07-13 Eingeleitet Citigroup Buy
2021-07-13 Eingeleitet Cowen Outperform
2021-07-13 Eingeleitet Credit Suisse Outperform
2021-07-13 Eingeleitet RBC Capital Mkts Sector Perform
2021-07-08 Eingeleitet Aegis Capital Buy
Alle ansehen

Atai Life Sciences N V Aktie (ATAI) Neueste Nachrichten

pulisher
Sep 03, 2025

What are the analyst revisions for Atai Life Sciences N.V.Is OSTX stock a good investment in YEARQuarterly Profit Summary & Free Verified High Yield Trade Plans - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Statistical indicators supporting Atai Life Sciences N.V.’s strengthQuarterly Trade Report & Trade Opportunity Analysis Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year? - Yahoo Finance

Sep 03, 2025
pulisher
Sep 03, 2025

Can Atai Life Sciences N.V. hit a new high this monthEntry Point & Advanced Technical Signal Analysis - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Atai Life Sciences N.V. see short term momentumJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time alert setup for Atai Life Sciences N.V. performanceWeekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Combining price and volume data for Atai Life Sciences N.V.2025 Market WrapUp & Stock Timing and Entry Methods - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Atai Life Sciences N.V. stock go up soonEarnings Overview Summary & Weekly Top Gainers Trade List - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What data driven models say about Atai Life Sciences N.V.’s future2025 Retail Activity & Reliable Volume Spike Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What institutional flow reveals about Atai Life Sciences N.V.Market Trend Review & Advanced Swing Trade Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of Atai Life Sciences N.V. visualizedMarket Growth Summary & Long-Term Safe Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using R and stats models for Atai Life Sciences N.V. forecasting2025 Investor Takeaways & Safe Entry Momentum Tips - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Smart tools for monitoring Atai Life Sciences N.V.’s price actionEarnings Summary Report & High Yield Equity Trading Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Tools to assess Atai Life Sciences N.V.’s risk profileMarket Sentiment Report & Free Daily Entry Point Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What are Atai Life Sciences N.V.’s recent SEC filings showingWeekly Trade Recap & Proven Capital Preservation Methods - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Atai Life Sciences N.V. undervalued by DCF analysisWeekly Profit Report & High Accuracy Trade Signal Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is a relief rally coming for Atai Life Sciences N.V. holdersQuarterly Trade Review & AI Based Buy and Sell Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Tools to monitor Atai Life Sciences N.V. recovery probability2025 Year in Review & Risk Controlled Swing Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What machine learning models say about Atai Life Sciences N.V.2025 Institutional Moves & Daily Chart Pattern Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will a bounce in Atai Life Sciences N.V. offer an exitWeekly Loss Report & Weekly Sector Rotation Insights - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Atai Life Sciences N.V. (ATAI)’s BPL-003 Achieves Robust Phase 2b Success in Treatment-Resistant Depression - Yahoo Finance

Sep 02, 2025
pulisher
Sep 02, 2025

Is Atai Life Sciences N.V. part of any ETF2025 Market Overview & Risk Controlled Swing Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Applying big data sentiment scoring on Atai Life Sciences N.V.Volume Spike & Long-Term Safe Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Has Atai Life Sciences N.V. found a price floor2025 Investor Takeaways & Weekly Chart Analysis and Guides - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Volume spikes in Atai Life Sciences N.V. stock – what they meanQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Predicting Atai Life Sciences N.V. trend using moving averages2025 Market WrapUp & Safe Capital Allocation Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Atai Life Sciences N.V.’s volatility index tracking explained2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Does Atai Life Sciences N.V. fit your quant trading modelGold Moves & AI Enhanced Trading Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How moving averages guide Atai Life Sciences N.V. tradingInflation Watch & Technical Pattern Based Buy Signals - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What the charts say about Atai Life Sciences N.V. todayTrade Entry Summary & Reliable Volume Spike Trade Alerts - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Can momentum traders help lift Atai Life Sciences N.V.Earnings Growth Summary & Fast Gain Stock Trading Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Does Atai Life Sciences N.V. qualify in momentum factor screeningJobs Report & Verified Short-Term Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Atai Life Sciences N.V. stock recover after recent dropQuarterly Profit Summary & Risk Controlled Daily Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Automated trading signals detected on Atai Life Sciences N.V.Quarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Atai Life Sciences N.V. trending in predictive chart models2025 Technical Patterns & Risk Controlled Swing Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What makes Atai Life Sciences N.V. stock price move sharplyMarket Risk Report & Safe Entry Momentum Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How hedge fund analytics apply to Atai Life Sciences N.V. stockQuarterly Trade Review & Reliable Entry Point Alerts - Newser

Aug 31, 2025

Finanzdaten der Atai Life Sciences N V-Aktie (ATAI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):